Literature DB >> 20204821

No sustained improvement in tumor oxygenation after localized mild hyperthermia.

Debra K Kelleher1, Peter Vaupel.   

Abstract

This study has attempted to address the controversy concerning sustained increases in tumor oxygenation upon localized mild hyperthermia. While some previous studies have reported transient increases, others have reported persistent increases in tumor oxygenation, lasting for upto 2 days after application of mild hyperthermia. In order to determine changes in oxygenation at clinically relevant tumor temperatures, experimental tumors in rats underwent localized hyperthermia at either 40, 41.8 degrees C or 43 degrees C for 1 h using water-filtered infrared-A irradiation. Oxygenation was continuously measured before, during and upto 60 min after hyperthermia in the tumors of anesthetized rats using oxygen-sensitive catheters. The data obtained indicate that localized hyperthermia can lead, on average to an improved tumor oxygenation, although this improvement is generally transient and no longer evident 1 h after heating. Since clinically relevant increases in oxygenation enduring beyond the heating period were rarely seen, it would appear that an improvement in the efficacy of oxygen-dependent cancer therapy is unlikely to be achieved in the post-hyperthermia period.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20204821     DOI: 10.1007/978-1-4419-1241-1_57

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  Hyperthermically induced changes in high spectral and spatial resolution MR images of tumor tissue--a pilot study.

Authors:  Sean Foxley; Xiaobing Fan; Jonathan River; Marta Zamora; Erica Markiewicz; Shunmugavelu Sokka; Gregory S Karczmar
Journal:  Phys Med Biol       Date:  2012-04-13       Impact factor: 3.609

Review 2.  Can nanomedicines kill cancer stem cells?

Authors:  Yi Zhao; Daria Y Alakhova; Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

Review 3.  Integrating Hyperthermia into Modern Radiation Oncology: What Evidence Is Necessary?

Authors:  Jan C Peeken; Peter Vaupel; Stephanie E Combs
Journal:  Front Oncol       Date:  2017-06-30       Impact factor: 6.244

4.  Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials.

Authors:  Linda Spiegelberg; Ruud Houben; Raymon Niemans; Dirk de Ruysscher; Ala Yaromina; Jan Theys; Christopher P Guise; Jeffrey B Smaill; Adam V Patterson; Philippe Lambin; Ludwig J Dubois
Journal:  Clin Transl Radiat Oncol       Date:  2019-01-18

Review 5.  The measurement and modification of hypoxia in colorectal cancer: overlooked but not forgotten.

Authors:  Teddy Fletcher; Alex J Thompson; Hutan Ashrafian; Ara Darzi
Journal:  Gastroenterol Rep (Oxf)       Date:  2022-08-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.